ロード中...
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
BACKGROUND: Ischemia-reperfusion injury (IRI) is a major challenge in liver transplantation. The mitochondrial pathway plays a pivotal role in hepatic IRI. Levosimendan, a calcium channel sensitizer, was shown to attenuate apoptosis after IRI in animal livers. The aim of this study was to investigat...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5690693/ https://ncbi.nlm.nih.gov/pubmed/29145424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187839 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|